NIH Release/Relock Socket
University of Washington
100 participants
Sep 1, 2020
INTERVENTIONAL
Conditions
Summary
The goal of the research is to create and evaluate a new technology for management of daily residual limb fluid volume fluctuation.
Eligibility
Inclusion Criteria10
- Had trans-tibial amputation at least 18 months prior to enrollment
- Regularly wear a definitive prosthesis for at least 7 hours per week
- Have a residual limb length of at least 9 cm
- K2 or higher MFCL
- Able to walk continuously with a prosthesis for at least 2 minutes at a time
- Sit, stand, and negotiate a step of 5.0 cm
- Have a spare prosthesis
- No cognitive issues
- Good hand dexterity and strength (not frail)
- Capable of communication over a video Zoom conference call.
Exclusion Criteria1
- Current presence of skin breakdown
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The participants will operate the test socket in one of two test conditions: (1) pin re-lock before panel re-lock and (2) panel re-lock before pin re-lock. Participants will test each of the two conditions in a random order, in lab, following a structured protocol. Tests will determine if the order of the re-lock mechanisms influences changes in limb volume.
The participants will operate the test socket in one of two test conditions: (1) pin re-lock before panel re-lock and (2) panel re-lock before pin re-lock. Participants will test each of the two conditions in a random order, out of lab, with no structured protocol. Tests will determine if the order of the re-lock mechanisms changes participant experience.
The participants will operate the test socket in one of two test conditions: (1) release/relock mechanisms enabled and (2) release/relock mechanisms disabled. Participants will test each of the two conditions in a random order, out of lab, with no structured protocol. Tests will determine how the novel release/relock mechanisms compare against traditional socket release methods.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04305782